Oral Pre-exposure Prophylaxis (PrEP)
0
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Design TherapeuticsCARLSBAD, CA
1 programStandard intervention: Offer PrEP choiceN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2024
2025
2026
Design TherapeuticsStandard intervention: Offer PrEP choice
Clinical Trials (1)
Total enrollment: 9,900 patients across 1 trials
PathToScale: An Implementation Evaluation
Start: Mar 2024Est. completion: Apr 20269,900 patients
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 9,900 patients
1 companies competing in this space